Partial Epilepsy
📧 Sign up to get email alerts when something new happens for Partial Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy [Phase 2]
This document announces the completion of a Phase 2 study of VX-765 in adults with treatment-resistant partial epilepsy.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy [Phase 3]
Open-label Phase 3 safety and efficacy study of levetiracetam in Korean patients with partial epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy [Phase 4]
Phase 4 trial evaluating the safety and efficacy of levetiracetam (Keppra) as monotherapy after conversion in subjects with partial epilepsy…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy [Phase 4]
This report notes the completion of a Phase 4 pharmacovigilance study (SKATE) evaluating the safety of Keppra (levetiracetam) as adjunctive …
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging
A completed clinical trial evaluating diffusion tensor imaging to improve lesion detection in children with MRI-negative partial epilepsy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy [Phase 3]
Phase 3 trial evaluating eslicarbazepine acetate as add-on therapy for adults with refractory partial epilepsy; results assess efficacy and …
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy [Phase 3]
This clinical trial update reports results from a Phase 3 study of BIA 2-093 in combination with other anti-epileptic drugs for partial epil…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy
A completed clinical trial evaluating thermographic assessment of skin temperature patterns in individuals with focal epilepsy.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy [Phase 3]
Phase 3 double-blind trial comparing zonisamide with carbamazepine as monotherapy in newly diagnosed partial epilepsy; the study assesses ef…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy [Phase 2]
An open-label extension study evaluating the safety and effectiveness of RWJ 333369 in epilepsy has completed Phase 2.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy [Phase 2]
Open-label extension study results for RWJ-333369 in epilepsy have completed Phase 2 evaluation, focusing on safety and effectiveness in pat…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy [Phase 2]
Phase 2 trial evaluating the safety and efficacy of 333369 for partial epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures [Phase 3]
Phase 3 trial update for pregabalin monotherapy in partial seizures (epilepsies, partial) has been terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Pediatric Epilepsy Study [Phase 3]
Novartis-sponsored Phase 3 pediatric epilepsy trial has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures [Phase 3]
Phase III open-label study evaluating gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures has completed, w…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients [Phase 4]
Phase 4 clinical trial comparing best medical practice with or without vagus nerve stimulation in pharmacoresistant partial epilepsy; the st…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients [Phase 3]
A Phase 3 pilot trial evaluating metabolism and weight changes in epilepsy patients treated with topiramate has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Metabolic Abnormalities in Children With Epilepsy
The NINDS-sponsored clinical trial investigating metabolic abnormalities in children with epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
This update notes that a clinical trial evaluating transcranial magnetic stimulation for poorly controlled partial epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-01Clinical Trial Update: To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy. [Phase 2]
Pfizer completed a Phase 2 study to evaluate the long-term safety of pregabalin in patients with refractory partial epilepsy.